RedChip Companies
|
|
Weekly Newsletter
|
|
Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia
|
Reviva Pharmaceuticals (Nasdaq: RVPH), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, announced over 30% enrollment in the US and initiation and ongoing enrollment across sites in Europe for the pivotal Phase 3 RECOVER study evaluating brilaroxazine for the treatment of schizophrenia. The Company also received regulatory approval for initiating the study in Asia (India), with enrollment at multiple sites in India expected in 2022.
For more information, visit www.revivapharma.com
|
Digital Ally Announces Next Generation Fleet Video Solution
Digital Ally (Nasdaq: DGLY) launched its next generation fleet vehicle video system, a full-featured solution utilizing the latest in telematics technology, including immediate driver-assist feedback that recognizes pedestrians, distracted or drowsy driving, and lane shifting.
|
Can-Fite Presented Positive New Data from it’s Phase III Psoriasis Study at an Industry Expert Summit in Boston
Dr. Pnina Fishman, CEO of Can-Fite BioPharma (NYSE American: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, delivered a presentation on the Company’s Phase 3 psoriasis data at the 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases in Boston.
|
|
|
Permex Petroleum Successfully Completes Drilling Phase of its First Breedlove Oilfield Well
Permex Petroleum (OTCQB: OILCF), a junior oil and gas company, announced successful completion of the drilling phase for its first Breedlove Oilfield well in Martin County, Texas. Since the beginning of 2022, the Company successfully recompleted five oil and gas wells, which came online at a combined initial production rate of 50 barrels of oil equivalent per day (“BOEPD”) and have stabilized at a rate of 35 BOEPD, increasing the Company’s total production to 71 BOEPD.
|
WHEN Group Acquires Controlling Stake in CrossMobile
WHEN Group (OTC: WHEN), a telecom and cybersecurity company with proprietary technologies developed to protect individuals and enterprises from cybersecurity threats, completed the acquisition of an additional 25% of CrossMobile Sp.z o.o. (“CrossMobile”), a licensed GSM telecom operator in Poland, providing the necessary licenses and key infrastructure to service the entire population of 450 million in the EU. The Company now holds approximately 51% of CrossMobile’s outstanding share capital on a fully diluted basis.
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: HPCO - Hempacco Co., Inc. |
| 4:15pm Eastern |
| Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California. |
|
|
|
|
|
| NASDAQ: DGLY- Digital Ally Inc. |
| 11:00am Eastern |
| Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. |
|
|
|
|
|
| NASDAQ: IINN - Inspira Technologies |
| 4:15pm Eastern |
| Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
|
| NASDAQ: APM - Aptorum Group |
| 4:15pm Eastern |
| Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs. |
|
|
|
|
|
| NASDAQ: DPRO - Draganfly |
| 4:15pm Eastern |
| Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. |
|
|
|
|
|
| NASDAQ: UNCY - Unicycive Therapeutics Inc. |
| 4:15pm Eastern |
| Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. |
|
|
Archive Events |
|
|
|
|
| NASDAQ: SVFD - Save Foods |
| Meeting Duration 45 minutes |
| Save Foods Inc and its Israeli subsidiary Save Foods Ltd are innovative, dynamic companies dedicated to delivering integrated eco-friendly solutions for improved safety, freshness and quality, every step of the way from field to fork. |
|
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| Meeting Duration 31 minutes |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in all weather and light conditions. |
|
|
|
|
|
| OTC: OBTX - Everything Blockchain |
| Meeting Duration 38 minutes |
| Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. |
|
|
|
|
|
| NASDAQ: NMRD - Nemaura Medical |
| Meeting Duration 31 minutes |
| Nemaura Medical is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT® and proBEAT™. |
|
|
|
|
|
| NASDAQ: SVFD - Save Foods |
| Meeting Duration 37 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
Lesson of the Week
Use dollar-cost averaging to build a position over time.
|
|
|
RedChip TV |
MidSouth Week in Review
Job vacancies jumped to 10.7 million vs. 10.3 in August.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
|
|
© 2022 RedChip , All rights reserved
|
|
| |
|
|
|
